Company research / ZYBT
Zhengye Biotechnology Holding Ltd (ZYBT)
- Sector Manufacturing
For the year ended 2025-12-31, Zhengye Biotechnology Holding Ltd reported revenue of 116.36M CNY. Revenue fell 37.6% from the prior annual period.
Key ratios (year ended 2025-12-31)
20.5%
Gross margin
-60.6%
Operating margin
-60.0%
Net margin
-22.8%
Return on year-end equity
-37.6%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.